Intelligent Medicine Acquisition Corp. (IQMD) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
9001 BURDETTE RD. BETHESDA, MD 20817 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 677 - Blank Checks (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 160,697 | 255,473 | 403,064 | 589,275 | 69,327 | |||
| Cash and cash equivalents | 160,697 | 255,473 | 403,064 | 589,275 | 69,327 | |||
| Prepaid expense | 146,804 | 169,339 | 191,187 | 157,975 | ||||
| Total current assets: | 307,501 | 424,812 | 594,251 | 747,250 | 69,327 | |||
| Noncurrent Assets | ||||||||
| Asset, held-in-trust | 212,402,618 | 211,449,605 | 211,164,490 | 211,143,228 | ||||
| Deferred costs | 813,772 | |||||||
| Other noncurrent assets | 14,071 | 45,903 | 77,043 | 103,970 | ||||
| Total noncurrent assets: | 212,416,689 | 211,495,508 | 211,241,533 | 211,247,198 | 813,772 | |||
| TOTAL ASSETS: | 212,724,190 | 211,920,320 | 211,835,784 | 211,994,448 | 883,099 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 937,280 | 550,602 | 324,397 | 208,500 | ||||
| Accounts payable | 937,280 | 550,602 | 324,397 | 208,500 | ||||
| Accrued liabilities | ||||||||
| Debt | 165,000 | |||||||
| Other undisclosed current liabilities | 15,000 | 15,000 | 28,373 | 28,373 | ||||
| Total current liabilities: | 952,280 | 565,602 | 352,770 | 236,873 | 165,000 | |||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 1,856,700 | 2,681,900 | 5,776,400 | |||||
| Derivative instruments and hedges, liabilities | 1,856,700 | 2,681,900 | 5,776,400 | |||||
| Other undisclosed noncurrent liabilities | 10,350,000 | 10,350,000 | 10,350,000 | 20,767,100 | ||||
| Total noncurrent liabilities: | 12,206,700 | 13,031,900 | 16,126,400 | 20,767,100 | ||||
| Other undisclosed liabilities | 715,033 | |||||||
| Total liabilities: | 13,158,980 | 13,597,502 | 16,479,170 | 21,003,973 | 880,033 | |||
| Temporary equity, carrying amount | 211,807,378 | 211,449,605 | 211,164,490 | 211,143,228 | ||||
| Equity | ||||||||
| Equity, attributable to parent, including: | (12,242,168) | (13,126,787) | (15,807,876) | (20,152,753) | 3,066 | |||
| Additional paid in capital | 24,482 | |||||||
| Accumulated deficit | (12,242,686) | (13,127,305) | (15,808,394) | (20,153,271) | (21,934) | |||
| Other undisclosed equity, attributable to parent | 518 | 518 | 518 | 518 | 518 | |||
| Other undisclosed equity | ||||||||
| Total equity: | (12,242,168) | (13,126,787) | (15,807,876) | (20,152,753) | 3,066 | |||
| TOTAL LIABILITIES AND EQUITY: | 212,724,190 | 211,920,320 | 211,835,784 | 211,994,448 | 883,099 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | ||
|---|---|---|---|---|---|---|---|
| Operating expenses | (268,579) | (404,744) | (305,823) | (75) | |||
| Operating loss: | (268,579) | (404,744) | (305,823) | (75) | |||
| Nonoperating income | 1,778,213 | 3,379,615 | 4,661,962 | ||||
| Investment income, nonoperating | 953,013 | 285,115 | 21,262 | ||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1,509,634 | 2,974,871 | 4,356,139 | (75) | |||
| Other undisclosed income from continuing operations before income taxes | |||||||
| Income (loss) from continuing operations before income taxes: | 1,509,634 | 2,974,871 | 4,356,139 | (75) | |||
| Income tax expense | (267,242) | (8,667) | |||||
| Income (loss) from continuing operations: | 1,242,392 | 2,966,204 | 4,356,139 | (75) | |||
| Income (loss) before gain (loss) on sale of properties: | ✕ | 1,242,392 | 2,966,204 | 4,356,139 | ✕ | (75) | |
| Other undisclosed net income | 10,000 | ||||||
| Net income (loss) attributable to parent: | 1,242,392 | 2,966,204 | 4,366,139 | (75) | |||
| Preferred stock dividends and other adjustments | (211,164,490) | ||||||
| Other undisclosed net income available to common stockholders, basic | |||||||
| Net income (loss) available to common stockholders, diluted: | 1,242,392 | 2,966,204 | (206,798,351) | (75) | |||
Comprehensive Income (USD)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,242,392 | 2,966,204 | 4,366,139 | (75) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | 1,242,392 | 2,966,204 | 4,366,139 | (75) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.